Clinical Trial Update: Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov record notes a Phase 3 trial evaluating cyclophosphamide, methotrexate, and fluorouracil with or without epirubicin hydrochloride in wom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Epirubicin hydrochloride (epirubicin hydrochloride)
• FLUOROURACIL (Fluorouracil)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN